Tilray Brands

TLRYNasdaq United States Health Care Medicinal Chemicals and Botanical Products

Market cap

$416.022 M

$2.82 -4.90%

Close of 6 Nov 2026

As of 6 Nov 2026, Tilray Brands (TLRY) has a market capitalization of $416.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$915.5M

#1560 by revenue

Earnings

-$121.4M

Loss-making

Shares outstanding

147,787,523

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medicinal Chemicals and Botanical Products, ranked by market cap

All 26 →

#7RLX TechnologyRLX$1.98B
#8Cronos GroupCRON$1.37B
#9Tilray BrandsTLRY$416.0M
#10Orchestra BioMedOBIO$340.2M
#11SndlSNDL$330.9M

Insiders buying

All insider buying →

3 open-market purchases by officers and directors of Tilray Brands, worth $69.2K. Grants and option exercises are excluded.

Mitchell GendelGlobal General Counsel$11.1K
2,500 shares at $4.43 on 6 Aug 2026 · filed 7 Aug 2026
Carl A. MertonChief Financial Officer$46.2K
10,000 shares at $4.62 on 4 Aug 2026 · filed 4 Aug 2026
Denise M. FaltischekChief Strategy Officer$11.9K
2,500 shares at $4.78 on 3 Aug 2026 · filed 4 Aug 2026

What if Tilray Brands were worth as much as…

Open the what-if tool →

Gold $28.2T

$191,063.99

Per share 67,874× higher

Bitcoin $1.53T

$10,338.14

Per share 3,673× higher

Apple $5.02T

$33,939.15

Per share 12,057× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Tilray Brands are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.